Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 264

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Series Introduction: Heparan sulfate proteoglycans: intricate molecules with intriguing functions

Open access
Iozzo, Renato V.·2001·Journal of Clinical Investigation

Abstract

Heparan sulfate proteoglycansThe term heparan sulfate proteoglycan (HSPG) refers to a dichotomous structure, a protein coupled to a unique glycosaminoglycan chain characterized by a linear array of alternating disaccharide units.Both the protein core and the side chains undergo a series of modification reactions, which endow them with a very complex fabric (1).The final product is a sophisticated compound that can fluctuate in size, fine structure, and biology (2-5).The complexity of a usual heparan sulfate chain, for instance, can easily surpass that of common nucleic acids (6, 7).The field of proteoglycan research is nearly equally split into two factions: those who feel that heparan sulfate is the prima donna, with the protein core being just a carrier, and those who feel that there would be no role for heparan sulfate without the protein core.The truth, as usual, is in the middle.Both possess unique features that in some respects act synergistically to provide the maximal strength of signaling and biological activity.This Perspective series, motivated by the recent flurry of discoveries, has been coordinated to provide a balanced view of the most recent advances in the field of HSPG research.The development of novel experimental strategies for decoding the sequence of heparan sulfate (8-10), together with the availability of antibodies specific for heparan sulfate epitopes (11), holds promise for deciphering the functional specificity of heparan sulfate in tissues.The medical importance is underscored by the direct involvement of HSPGs in various human diseases involving the musculoskeletal system, such as the Schwartz-Jampel chondrodystrophic myotonia (12) and the dyssegmental dysplasia Silverman-Handmaker type (13), overgrowth syndrome (Simpson-Golabi-Behmel) (14), or hereditary bone disorders (hereditary multiple exostoses) (15). A few take-home messagesThe heparan sulfate chains vary in length from ∼5 to ∼70 kDa.This is an important and often forgotten point.Glycosaminoglycan chains, joined to the polypeptide, also enjoy ample freedom to move laterally.These linear polymers can reach distant targets that can be located several hundreds of nanometers

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci13560

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 264

Metadata

Authors
Iozzo, R. V.
Venue
Journal of Clinical Investigation
Published
2001-07-15
Volume
108
Issue
2
Pages
165-167
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2137756512
Cited by
264
References
15
FWCI
6.46
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Series Introduction: Heparan sulfate proteoglycans: intricate molecules with intriguing functions. https://app.cochat.ai/papers/10.1172/jci13560
The paper
Iozzo, R. V. (2001). Series Introduction: Heparan sulfate proteoglycans: intricate molecules with intriguing functions. Journal of Clinical Investigation. https://doi.org/10.1172/jci13560

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.